Winton Group LTD Corcept Therapeutics Inc Transaction History

Winton Group LTD

$1.35 Billion
Q1 2024

A detailed history of Winton Group LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Winton Group LTD holds 40,272 shares of CORT stock, worth $1.23 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

40,272

Previous 15,497 159.87%

Holding current value

$1.23 Million

Previous $503,000 101.59%

% of portfolio

0.08%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$21.1 - $27.46 $522,752 - $680,321	24,775 Added 159.87%	40,272 $1.01 Million
Q4 2023 Feb 12, 2024	BUY	$24.82 - $32.88 $546 - $723	22 Added 0.14%	15,497 $503,000
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $159,238 - $244,982	-7,248 Reduced 31.9%	15,475 $421,000
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $1.9 Million - $2.23 Million	-88,850 Reduced 79.63%	22,723 $505,000
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $4,416 - $5,628	230 Added 0.21%	111,573 $2.42 Million

Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $146,093 - $219,397	7,323 Added 7.04%	111,343 $2.26 Million
Q3 2022 Nov 10, 2022	SELL	$24.7 - $29.12 $625,502 - $737,434	-25,324 Reduced 19.58%	104,020 $2.67 Million
Q2 2022 Aug 10, 2022	BUY	$17.33 - $25.3 $211,356 - $308,558	12,196 Added 10.41%	129,344 $3.08 Million
Q1 2022 May 11, 2022	SELL	$16.53 - $25.21 $23,505 - $35,848	-1,422 Reduced 1.2%	117,148 $2.64 Million
Q4 2021 Feb 10, 2022	SELL	$17.1 - $23.34 $64,193 - $87,618	-3,754 Reduced 3.07%	118,570 $2.35 Million
Q3 2021 Oct 28, 2021	BUY	$19.68 - $22.53 $188,711 - $216,040	9,589 Added 8.51%	122,324 $2.41 Million
Q2 2021 Aug 10, 2021	BUY	$19.97 - $24.43 $147,438 - $180,366	7,383 Added 7.01%	112,735 $2.48 Million
Q1 2021 Jul 21, 2021	SELL	$23.49 - $30.56 $121,137 - $157,597	-5,157 Reduced 4.67%	105,352 $2.51 Million
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $4.16 Million - $6.76 Million	-247,769 Reduced 69.16%	110,509 $2.89 Million
Q3 2020 Oct 30, 2020	SELL	$12.46 - $19.98 $2.34 Million - $3.75 Million	-187,868 Reduced 34.4%	358,278 $6.24 Million
Q2 2020 Aug 05, 2020	SELL	$11.0 - $18.26 $953,183 - $1.58 Million	-86,653 Reduced 13.69%	546,146 $9.19 Million
Q1 2020 May 11, 2020	SELL	$10.11 - $14.04 $228,435 - $317,233	-22,595 Reduced 3.45%	632,799 $7.52 Million
Q4 2019 Feb 13, 2020	BUY	$12.06 - $16.96 $7.18 Million - $10.1 Million	595,403 Added 992.49%	655,394 $7.93 Million
Q3 2019 Nov 08, 2019	BUY	$10.41 - $14.66 $368,638 - $519,139	35,412 Added 144.07%	59,991 $848,000
Q2 2019 Jul 08, 2019	BUY	$9.78 - $12.76 $240,382 - $313,628	24,579 New	24,579 $274,000
Q1 2019 May 13, 2019	SELL	$10.03 - $15.71 $125,826 - $197,081	-12,545 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$11.29 - $17.19 $81,208 - $123,647	-7,193 Reduced 36.44%	12,545 $168,000
Q3 2018 Nov 02, 2018	SELL	$12.27 - $15.65 $36,270 - $46,261	-2,956 Reduced 13.03%	19,738 $0
Q2 2018 Aug 20, 2018	SELL	$15.3 - $19.69 $199,343 - $256,541	-13,029 Reduced 36.47%	22,694 $0
Q1 2018 May 21, 2018	BUY	$14.59 - $25.5 $521,198 - $910,936	35,723 New	35,723 $0

Others Institutions Holding CORT

# of Institutions

316

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.27B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account